This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

WEB REGISTRATION CLOSES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center
Book Now
Menu
Book Now

Dr. Michael Cochran, PhD
Director of Chemistry at Avidity Biosciences
Speaker

Profile

Scientist with over ten years of experience in industry developing antibody-oligonucleotide conjugates, nanoparticles, and antigen-adjuvant conjugates to improve treatments for rare muscular diseases, oncology, and vaccines. At Avidity, Michael has worked on the chemistry of antibody-siRNA and PMO conjugates from preclinical discovery through GMP manufacturing.

Agenda Sessions

  • Recent Progress with Antibody PMO Conjugates

    , 10:45am
    View Session

At this event

Prev
Next
Dr. Jeffery Coller, PhD
Bloomberg Distinguished Professor of RNA Biology and Therapeutics
Johns Hopkins University

See Michael at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now